Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Antimicrobial Agents and Chemotherapy|October 27, 2020
First Penicillin-Binding Protein Occupancy Patterns for 15 β-Lactams and β-Lactamase Inhibitors in Mycobacterium abscessusAlaa R M Sayed, Nirav R Shah, Kari B Basso, et al.Antimicrobial Agents and Chemotherapy|January 30, 2024
Population pharmacokinetics and humanized dosage regimens matching the peak, area, trough, and range of amikacin plasma concentrations in immune-competent murine bloodstream and lung infection modelsYuanyuan Jiao, Jun Yan, Dhruvitkumar S Sutaria, et al.Antimicrobial Agents and Chemotherapy|April 17, 2019
Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled TrialsYuanyuan Jiao, Bartolome Moya, Mong-Jen Chen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2023
A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate CancerDavid Pook, Daniel M Geynisman, Joan Carles, et al.Mbio|February 13, 2020
Novel Cassette Assay To Quantify the Outer Membrane Permeability of Five β-Lactams Simultaneously in Carbapenem-Resistant <i>Klebsiella pneumoniae</i> and <i>Enterobacter cloacae</i>Tae Hwan Kim, Xun Tao, Bartolome Moya, et al.The Lancet. Oncology|April 30, 2026
Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trialSeth A Wander, Maxwell R Lloyd, Jennifer C Keenan, et al.Clinical Pharmacology and Therapeutics|February 12, 2021
Combating Multidrug-Resistant Bacteria by Integrating a Novel Target Site Penetration and Receptor Binding Assay Platform Into Translational ModelingYinzhi Lang, Nirav R Shah, Xun Tao, et al.Pageof 3